Production (Stage)
OneMedNet Corporation
ONMD
$0.409
$0.00090.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -92.35% | -56.44% | 31.21% | 24.00% | 28.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -92.35% | -56.44% | 31.21% | 24.00% | 28.89% |
| Cost of Revenue | -84.62% | -22.87% | 43.04% | 9.69% | -16.97% |
| Gross Profit | -1,400.00% | -354.55% | -78.95% | 22.47% | 101.39% |
| SG&A Expenses | 67.76% | 28.94% | 110.59% | 98.87% | -81.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.92% | 12.25% | 53.73% | 40.74% | -72.17% |
| Operating Income | -42.72% | -23.87% | -56.21% | -43.02% | 75.65% |
| Income Before Tax | 4.28% | 85.13% | 62.62% | 73.05% | -26.58% |
| Income Tax Expenses | -88.89% | -- | -- | -- | -91.62% |
| Earnings from Continuing Operations | 4.89% | 85.13% | 62.62% | 73.05% | -14.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.89% | 85.13% | 62.62% | 73.05% | -14.89% |
| EBIT | -42.72% | -23.87% | -56.21% | -43.02% | 75.65% |
| EBITDA | -42.01% | -23.74% | -56.27% | -42.86% | 75.74% |
| EPS Basic | 57.34% | 97.72% | 93.70% | 95.41% | 47.80% |
| Normalized Basic EPS | 57.27% | 97.72% | 93.68% | 95.37% | 66.21% |
| EPS Diluted | 57.34% | 97.72% | 93.70% | 95.41% | 47.80% |
| Normalized Diluted EPS | 57.27% | 97.72% | 93.68% | 95.37% | 66.21% |
| Average Basic Shares Outstanding | 122.94% | 551.24% | 493.58% | 487.17% | 120.14% |
| Average Diluted Shares Outstanding | 122.94% | 551.24% | 493.58% | 487.17% | 120.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |